{"id":1103,"date":"2024-05-25T12:37:27","date_gmt":"2024-05-25T12:37:27","guid":{"rendered":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/startup\/sph-therapeutics\/"},"modified":"2026-04-04T00:29:57","modified_gmt":"2026-04-04T00:29:57","slug":"sph-therapeutics","status":"publish","type":"startup","link":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/startup\/sph-therapeutics\/","title":{"rendered":"Sphingolipid-derived cancer nanotherapeutics"},"content":{"rendered":"","protected":false},"featured_media":1118,"parent":0,"template":"","startup-category":[],"industry":[6],"opportunity":[23,24,26],"class_list":["post-1103","startup","type-startup","status-publish","has-post-thumbnail","hentry","industry-pharma","opportunity-ceo-business-lead","opportunity-co-founder","opportunity-cso"],"acf":[],"_links":{"self":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup\/1103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup"}],"about":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/types\/startup"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/media\/1118"}],"wp:attachment":[{"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/media?parent=1103"}],"wp:term":[{"taxonomy":"startup-category","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/startup-category?post=1103"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/industry?post=1103"},{"taxonomy":"opportunity","embeddable":true,"href":"https:\/\/techlaunch-static.arizona.edu\/startuphub\/wp-json\/wp\/v2\/opportunity?post=1103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}